中新网北京12月13日电 (记者刘育英)12月13日，在"2026中国信通院深度观察报告会"上，中国信息通信 研究院知识产权与创新发展中心主任李文宇表示，2025年我国脑机接口产业发展成效显著，在核心技术 突破、多场景应用落地及产业生态构建等方面均实现重要进展，为行业规模化发展与高质量升级奠定坚 实基础。 李文宇表示，在核心器件方面，我国自主研发的多款脑机接口芯片、植入式电极等器件的通道数持续增 加，稳定性逐步提升。整机系统的集成水平和综合性能同步优化，无线、无源、小型化整机系统频出， 部分技术指标已接近或达到国际先进水平，为后续临床转化与商业化应用筑牢根基。 在解码算法方面，人工智能技术的快速应用极大提升了解码精度，成功实现对被试者精细运动意图的解 码，让手写解码、语音解码等高难度解码场景成为可能。 非侵入式脑机接口则重点布局生活消费与工业领域，多款非侵入式整机设备已实现量产，在疲劳监测、 情绪识别、脑控外设、智能驾驶等场景开展试点应用，逐步构建起多场景应用生态，加速从技术验证向 规模化落地的跨越，为未来大规模商用铺平道路。 在分析2025年我国脑机接口产业生态的新特征时，李文宇指出，产业已形成"政策-科研 ...

Core Insights - The first brain-computer interface (BCI) surgery in China was successfully completed at Tongji Hospital in Wuhan, marking a significant step in integrating BCI technology into the medical service pricing system [1][2] - The surgery was performed on a paraplegic patient and was funded by research grants, highlighting the importance of establishing a clear pricing standard for BCI procedures [1][2] - The procedure utilized a BCI device produced by Wuhan Zhonghua Brain-Machine Fusion Technology Development Co., which specializes in BCI technology research and industrialization [2] Industry Developments - The National Healthcare Security Administration guided the establishment of a standardized pricing for invasive BCI procedures, setting the cost at 6,552 yuan per operation, which facilitates the inclusion of BCI technology into the regular medical service system [1] - The successful implementation of this surgery indicates a shift from research exploration to clinical application, paving the way for broader adoption of BCI technology in medical practices [1][2] - Zhonghua Brain-Machine is focused on developing implantable BCI systems, neural signal processing algorithms, and clinical application solutions, positioning itself as a key player in the BCI industry [2]

（文章来源：第一财经） 马斯克在社交平台分享消息称，其旗下脑机接口公司Neuralink的首位人类受试者诺兰·阿博正计划进行 第二次植入，有望恢复腿部活动能力。 ...

新华社北京11月21日电 《经济参考报》11月21日刊发文章《触摸"十五五"产业脉搏丨思维现实加 速"链接" 脑机接口迈入产业化快车道》。文章称，在资本市场上，脑机接口正成为投资者的关注焦 点。不仅相关板块今年以来最高涨幅超过60%，创投方面的相关投资额也实现大幅度增长。资本热捧背 后，是脑机接口技术研发的全链条推进，应用案例的持续涌现，以及产业链的加速完善。 "十五五"期间，在政府、企业、科研机构等各方合力推动下，脑机接口这一连接思维与现实的人机交互 关键技术，有望撬动百亿级产业规模，为医疗、消费等领域带来深刻变革。 中国科学院深圳先进技术研究院研究员刘志远表示，该研究首次提出脑机接口"动态电极"新范式，打破 植入式电极的"静态"传统。 先进院的突破是我国脑机接口发展的生动体现，今年以来，我国脑机接口技术不仅在底层技术上有所突 破，临床应用探索也持续推进，首次案例正在涌现。 不久前，华中科技大学同济医学院附属协和医院完成全国产自主研发脑机接口芯片"汉产"首例临床植入 手术，成功采集到了患者大脑中感觉运动区域的神经信号。 术后经过一个多月的系统训练，患者原本无法活动的大拇指功能明显改善，并能完成抓握水瓶、将瓶 ...

Group 1 - Morgan Stanley predicts that the MSCI China Index may rise over 3% to 90 points by the end of next year, with year-end targets for the Hang Seng Index at 27,500 points and the CSI 300 Index at 4,840 points, representing increases of approximately 4% and 5% respectively [1] - Semiconductor company SMIC has received a large number of urgent orders for storage products, including NOR/NAND Flash and MCU, leading to a temporary decrease in mobile phone business share as non-urgent orders are postponed [1][2] - XPeng Motors reported Q3 revenue of 20.38 billion yuan, a year-on-year increase of 101.8% and a quarter-on-quarter increase of 11.5%, while net loss narrowed to 380 million yuan from 1.81 billion yuan a year earlier [1][3] Group 2 - The Ministry of Finance reported that securities transaction stamp duty revenue in October was 18.1 billion yuan, a year-on-year increase of 17.53% but a month-on-month decrease of 30.7%, indicating a cooling in market trading activity [1][5] - The National Medical Products Administration has issued guidelines to support the development of the cosmetics industry, particularly focusing on products for the elderly, aligning with the national strategy for the aging population [1][6] - Berkshire Hathaway's investment in Google has seen a floating profit of over 45% since acquiring shares at an average price of $200 in Q3, with expectations for the upcoming release of Google's AI model, Gemini 3.0 [1][7] Group 3 - The first clinical implantation of a domestically developed brain-computer interface chip has been successfully completed, marking a significant milestone for China's chip development [1][9] - In October, 19 provinces in China reported infrastructure project commencement rates exceeding 50%, indicating strong momentum in the construction sector [1][10] - Guangdong province is increasing direct financing support for the silver economy, reflecting a growing focus on the needs of the elderly population [1][10]

Core Insights - A new brain-machine interface chip thinner than a human hair has been developed, showing potential for treating neurological diseases such as Parkinson's and epilepsy, and opening new avenues in biomedical engineering [1][2] Group 1: Technology Development - The MIT Media Lab team has created a brain-machine interface chip using a novel organic semiconductor material, which is attached to immune cells and delivered via intravenous injection [2] - This technology allows for non-invasive implantation of the device into the brain, overcoming the limitations of current invasive methods that require surgical procedures [1][2] Group 2: Clinical Application and Market Potential - The research is in the early stages of transitioning from basic research to clinical application, with successful in vivo experiments conducted on live animals [1][2] - The recent approval of a wireless implanted brain-machine interface system by Shanghai Ladder Medical Technology Co., Ltd. marks a significant step for invasive brain-machine interface technology in China, facilitating faster market entry [2][3] Group 3: Future Implications - The brain-machine interface technology has the potential to significantly benefit patients with paralysis, speech impairments, and other neurological disorders, possibly enabling quicker recovery for those who have lost consciousness [3] - Collaboration across multiple disciplines, including materials science, artificial intelligence, and medicine, is essential for the advancement of brain-machine interface technology [3]

Core Insights - Brain-computer interface (BCI) technology has made significant advancements, exemplified by a video showing an ALS patient using a Neuralink chip to control a robotic arm to drink water independently for the first time in eight years [1][3]. Industry Overview - The BCI industry integrates neuroscience, artificial intelligence, and microelectronics, enabling direct interaction between thoughts and external devices [3]. - The Chinese government has prioritized BCI technology, including it in the "14th Five-Year Plan" and the 2035 vision as a key frontier technology project [3][8]. Market Dynamics - The healthcare sector is identified as the primary downstream application area for BCI technology, with 56% of companies in China focusing on medical applications [3]. - Clinical trials are underway in major hospitals, such as Shanghai Ruijin Hospital for Parkinson's disease and Beijing Tiantan Hospital for depression treatment [3]. Competitive Landscape - China leads the global BCI field with a patent application share of 55.62%, significantly surpassing the United States, which has 402 applications [6]. Regulatory Environment - The National Healthcare Security Administration in China has established pricing guidelines for BCI services, indicating a structured path for clinical application and reimbursement once the technology matures [8]. Research and Development - Advances in bidirectional BCI technology could potentially treat various neurological disorders, including epilepsy, Parkinson's disease, Alzheimer's disease, and mental health issues, while also aiding in spinal cord injury rehabilitation [9].

Core Insights - Neuralink, founded by Elon Musk, focuses on developing brain-computer interface (BCI) technology to treat various neurological issues, including blindness and mental disorders [3][4] - The company announced that 12 patients globally have used its brain implant devices for a total of over 2,000 days, accumulating 15,335 hours of usage, marking a significant milestone in long-term human use of BCI technology [3] - The first public trial participant, Noland Arbaugh, who became paralyzed from the waist down after a swimming accident in 2016, has resumed playing video games and learning languages after receiving the Neuralink implant, highlighting the technology's potential to restore lost functions [3] - Neuralink has made progress in international trials, completing its first overseas surgeries in Toronto, Canada, as part of a four-year clinical trial to assess whether quadriplegic patients can control electronic devices through thought [3] - In addition to Canada, Neuralink is conducting the GB-PRIME clinical study in the UK, which has received regulatory approval to evaluate how paralyzed patients can interact with the digital world using the implanted device, indicating the company's acceleration of global expansion and technology validation [4] - Elon Musk aims to reduce the cost of BCI devices and surgeries to a few thousand dollars to make the technology accessible to more people, and since receiving FDA approval for human trials in 2023, Neuralink has been expanding its trial scale [4]

Group 1 - The core viewpoint of the reports indicates that the brain-computer interface (BCI) industry is in its early commercialization stage, primarily driven by thematic investment styles [1] - The report suggests focusing on invasive and non-invasive BCIs based on different standards, with invasive BCIs like Aipeng Medical, Gaode Infrared, and Yanshan Technology showing faster clinical progress, while non-invasive BCIs like Xiangyu Medical, Innovation Medical, and Chengyitong are advancing in commercialization [1] - Policy support for BCI development is evident in three areas: funding, planning, and payment, with significant investments from major countries and specific policies being introduced in China to promote rapid industry growth [1] Group 2 - Continuous technological breakthroughs in electrodes, chips, and algorithms are providing a foundation for accelerated industrialization, with advancements in both non-invasive and invasive electrode technologies enhancing signal quality and safety [2] - Chip development is progressing towards high-channel, low-power, and high-speed solutions, with several institutions in China breaking foreign monopolies in this area [2] - The algorithmic focus is shifting towards closed-loop BCI systems, which enhance real-time feedback and control, significantly improving efficiency and accuracy in applications [2] Group 3 - The healthcare sector is identified as the core market for BCI applications, with projections indicating a potential global market size of $6.5 billion by 2035 [3] - Non-invasive BCIs are expected to see the fastest penetration due to their safety and ease of use, with rehabilitation products leading the commercialization efforts [3] - Invasive BCIs are targeting high-precision and high-value areas such as epilepsy and neurodevelopmental disorders, with ongoing clinical advancements in rehabilitation and language decoding [3]

Investment Rating - The industry investment rating is "Overweight (Maintain)" [1] Core Viewpoints - The report emphasizes that the brain-computer interface (BCI) industry is experiencing continuous innovation and rapid growth, becoming a crucial area for the integration of technological and industrial innovation [8] - The report highlights the government's recent policy initiatives aimed at enhancing the innovation capabilities of the BCI industry, which are expected to drive high-quality development and create new industrial pathways [8] Summary by Sections Industry Overview - The report focuses on the pharmaceutical and biotechnology industry, particularly the advancements in brain-computer interface technology [1] Recent Developments - A joint document from seven government departments outlines plans to boost the BCI industry, aiming for breakthroughs in key technologies by 2027 and establishing a robust industrial ecosystem by 2030 [3][4] Investment Recommendations - The report suggests monitoring companies such as Aipeng Medical, Innovation Medical, and Xiangyu Medical, which are positioned to benefit from the growth in the BCI sector [8]